New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
Amylin Pharmaceuticals (AMLN)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Cash Flow Statement (USD)
Annual
|
Quarterly
QUARTER ENDING
30-JUN
2011
30-SEP
2011
31-DEC
2011
31-MAR
2012
30-JUN
2012
Net Income
-31.4M
-13.2M
-461M
-99.0M
-74.2M
Depreciation
0
0
0
0
46.7M
Amortization
0
0
0
0
10.9M
Deferred Taxes
0
0
0
0
0
Change In Working Capital
0
0
0
0
-76.0M
Other Non Cash Operating Items
0
0
0
0
109M
Cash From Operations
0
0
0
0
-82.5M
Capital Expenditures
0
0
0
0
-21.5M
Sale of Assets
0
0
0
0
0
Acquisitions
0
0
0
0
0
Investments
0
0
0
0
-258M
Other Investing Activities
0
0
0
0
107M
Cash from Investing
0
0
0
0
-151M
Dividends Paid
0
0
0
0
0
Sale / Purchase of Stock
0
0
0
0
235M
Net Borrowings
0
0
0
0
0
Other Financing Cash Flows
0
0
0
0
-6.09M
Cash From Financing
0
0
0
0
229M
Foreign Exchange Effect
0
0
0
0
0
Net Change in Cash
0
0
0
0
-4.62M
Add Metric
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour